Literature DB >> 6808210

Platinum-complexed antitumor immunoglobulins that specifically inhibit DNA synthesis of mouse tumor cells.

E Hurwitz, R Kashi, M Wilchek.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6808210

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  4 in total

1.  Targeting of neoglycoprotein-drug conjugates to cultured human embryonal carcinoma cells.

Authors:  H J Gabius; C Bokemeyer; T Hellmann; H J Schmoll
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

Review 2.  Metal-based antibody drug conjugates. Potential and challenges in their application as targeted therapies in cancer.

Authors:  Virginia Del Solar; María Contel
Journal:  J Inorg Biochem       Date:  2019-07-18       Impact factor: 4.155

Review 3.  Advances in platinum cancer chemotherapy. Advances in the design of cisplatin analogues.

Authors:  P C Hydes; M J Russell
Journal:  Cancer Metastasis Rev       Date:  1988-04       Impact factor: 9.264

4.  In vitro activity of immunoconjugates between cisplatin and an anti-CA125 monoclonal antibody on ovarian cancer cell lines.

Authors:  E Beck; M Hofmann; G Bernhardt; W Jäger; L Wildt; N Lang
Journal:  Cell Biophys       Date:  1994
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.